On September 25th, we had an interview with CEO Dr. Jennifer Bath of Immunoprecise Antibodies and below is a short summary on the Company and our video interview.
About ImmunoPrecise Antibodies Ltd. ImmunoPrecise is a global technology platform company with end-to-end solutions empowering companies to discover and develop therapies against any disease. The Company's experience and cutting-edge technologies enable unparalleled support of its partners in their quest to bring innovative treatments to the clinic. ImmunoPrecise's full-service capabilities dramatically reduce the time required for, and the inherent risk associated with, conventional multi-vendor product development. For further information, visit www.immunoprecise.com or contact solutions@immunoprecise.com.
|